Amplifon (OTCMKTS:AMFPF – Get Free Report) is one of 95 public companies in the “Medical Services” industry, but how does it compare to its competitors? We will compare Amplifon to similar companies based on the strength of its earnings, analyst recommendations, institutional ownership, profitability, dividends, risk and valuation.
Profitability
This table compares Amplifon and its competitors’ net margins, return on equity and return on assets.
Net Margins | Return on Equity | Return on Assets | |
Amplifon | 5.90% | 13.68% | 3.97% |
Amplifon Competitors | -760.08% | -30.10% | -13.70% |
Earnings & Valuation
This table compares Amplifon and its competitors revenue, earnings per share and valuation.
Gross Revenue | Net Income | Price/Earnings Ratio | |
Amplifon | $2.61 billion | $157.31 million | 35.07 |
Amplifon Competitors | $9.23 billion | $234.98 million | 1.63 |
Volatility and Risk
Amplifon has a beta of 0.53, indicating that its stock price is 47% less volatile than the S&P 500. Comparatively, Amplifon’s competitors have a beta of 1.65, indicating that their average stock price is 65% more volatile than the S&P 500.
Institutional & Insider Ownership
57.3% of shares of all “Medical Services” companies are held by institutional investors. 12.9% of shares of all “Medical Services” companies are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.
Analyst Recommendations
This is a summary of current recommendations and price targets for Amplifon and its competitors, as reported by MarketBeat.com.
Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
Amplifon | 0 | 1 | 1 | 0 | 2.50 |
Amplifon Competitors | 420 | 2240 | 4802 | 151 | 2.62 |
As a group, “Medical Services” companies have a potential upside of 430.69%. Given Amplifon’s competitors stronger consensus rating and higher probable upside, analysts clearly believe Amplifon has less favorable growth aspects than its competitors.
Summary
Amplifon competitors beat Amplifon on 9 of the 13 factors compared.
About Amplifon
Amplifon S.p.A. engages in the distribution of hearing solutions and the fitting of customized products that help people rediscover various emotions of sound in Europe, the Middle East, Africa, the Americas, and the Asia Pacific. The company offers Ampli-easy, Ampli-connect, Ampli-energy, and Ampli-mini hearing devices. It also operates Ampli-care, a platform to deliver audiological care experience; and Amplifon App to manage the device functions in real-time directly from smartphone. Amplifon S.p.A. was founded in 1950 and is headquartered in Milan, Italy. Amplifon S.p.A.
Receive News & Ratings for Amplifon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amplifon and related companies with MarketBeat.com's FREE daily email newsletter.